247 related articles for article (PubMed ID: 24357184)
1. Cyclooxygenase-2 and inflammation mediators have a crucial role in reflux-related esophageal histological changes and Barrett's esophagus.
Taddei A; Fabbroni V; Pini A; Lucarini L; Ringressi MN; Fantappiè O; Bani D; Messerini L; Masini E; Bechi P
Dig Dis Sci; 2014 May; 59(5):949-57. PubMed ID: 24357184
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of VEGF, COX-2, and Ki-67 in Barrett's esophagus: does the length matter?
Zampeli E; Karamanolis G; Morfopoulos G; Xirouchakis E; Kalampoki V; Michopoulos S; Savva S; Tzias V; Zouboulis-Vafiadis I; Kamberoglou D; Ladas SD
Dig Dis Sci; 2012 May; 57(5):1190-6. PubMed ID: 22147251
[TBL] [Abstract][Full Text] [Related]
3. Proinflammatory cytokine and nuclear factor kappa-B expression along the inflammation-metaplasia-dysplasia-adenocarcinoma sequence in the esophagus.
O'Riordan JM; Abdel-latif MM; Ravi N; McNamara D; Byrne PJ; McDonald GS; Keeling PW; Kelleher D; Reynolds JV
Am J Gastroenterol; 2005 Jun; 100(6):1257-64. PubMed ID: 15929754
[TBL] [Abstract][Full Text] [Related]
4. Esophageal mucosal eicosanoids in gastroesophageal reflux disease and Barrett's esophagus.
Triadafilopoulos G; Kaczynska M; Iwane M
Am J Gastroenterol; 1996 Jan; 91(1):65-74. PubMed ID: 8561146
[TBL] [Abstract][Full Text] [Related]
5. Interaction of epidermal growth factor with COX-2 products and peroxisome proliferator-activated receptor-γ system in experimental rat Barrett's esophagus.
Majka J; Wierdak M; Szlachcic A; Magierowski M; Targosz A; Urbanczyk K; Krzysiek-Maczka G; Ptak-Belowska A; Bakalarz D; Magierowska K; Chmura A; Brzozowski T
Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G375-G389. PubMed ID: 31928220
[TBL] [Abstract][Full Text] [Related]
6. Indomethacin but not a selective cyclooxygenase-2 inhibitor inhibits esophageal adenocarcinogenesis in rats.
Esquivias P; Morandeira A; Escartín A; Cebrián C; Santander S; Esteva F; García-González MA; Ortego J; Lanas A; Piazuelo E
World J Gastroenterol; 2012 Sep; 18(35):4866-74. PubMed ID: 23002358
[TBL] [Abstract][Full Text] [Related]
7. Acidic Bile Salts Induce Epithelial to Mesenchymal Transition via VEGF Signaling in Non-Neoplastic Barrett's Cells.
Zhang Q; Agoston AT; Pham TH; Zhang W; Zhang X; Huo X; Peng S; Bajpai M; Das K; Odze RD; Spechler SJ; Souza RF
Gastroenterology; 2019 Jan; 156(1):130-144.e10. PubMed ID: 30268789
[TBL] [Abstract][Full Text] [Related]
8. [The influence of Barrett's esophagus on the clinical signs and postoperative results of GERD].
Endzinas Z; Mickevicius A; Kiudelis M
Zentralbl Chir; 2004 Apr; 129(2):99-103. PubMed ID: 15106039
[TBL] [Abstract][Full Text] [Related]
9. Association of esophageal inflammation, obesity and gastroesophageal reflux disease: from FDG PET/CT perspective.
Wu YW; Tseng PH; Lee YC; Wang SY; Chiu HM; Tu CH; Wang HP; Lin JT; Wu MS; Yang WS
PLoS One; 2014; 9(3):e92001. PubMed ID: 24642729
[TBL] [Abstract][Full Text] [Related]
10. Characterization of acid and alkaline reflux in patients with Barrett's esophagus. G.O.S.P.E. Operative Group for the study of Esophageal Precancer.
D'Onofrio V; Bovero E; Iaquinto G
Dis Esophagus; 1997 Jan; 10(1):16-22; discussion 22-3. PubMed ID: 9079268
[TBL] [Abstract][Full Text] [Related]
11. [The clinical, pathological features and expression of Ki-67 and COX-2 in severe reflux esophagitis and Barrett's esophagus].
Chen X; Ouyang Q; Zhang WY; Li XS; Liang HL
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):207-9. PubMed ID: 15807268
[TBL] [Abstract][Full Text] [Related]
12. Detailed esophageal function and morphological analysis shows high prevalence of gastroesophageal reflux disease and Barrett's esophagus in patients with cervical inlet patch.
Rosztóczy A; Izbéki F; Németh IB; Dulic S; Vadászi K; Róka R; Gecse K; Gyökeres T; Lázár G; Tiszlavicz L; Wittmann T
Dis Esophagus; 2012 Aug; 25(6):498-504. PubMed ID: 22107367
[TBL] [Abstract][Full Text] [Related]
13. Nitric oxide (NO)-releasing aspirin exhibits a potent esophagoprotection in experimental model of acute reflux esophagitis. Role of nitric oxide and proinflammatory cytokines.
Pawlik M; Pajdo R; Kwiecien S; Ptak-Belowska A; Sliwowski Z; Mazurkiewicz-Janik M; Konturek SJ; Pawlik WW; Brzozowski T
J Physiol Pharmacol; 2011 Feb; 62(1):75-86. PubMed ID: 21451212
[TBL] [Abstract][Full Text] [Related]
14. Lipid droplet biogenesis and COX-2 pathway activation are triggered by Barrett's esophagus and adenocarcinoma, but not esophageal squamous cell carcinoma risk factors.
Carrossini N; Meireles Da Costa N; Andrade-Barreto E; Sousa VPL; Nicolau-Neto P; Souza-Santos PT; Mansur GR; Wernersbach L; Bozza PT; Viola JPB; Ribeiro Pinto LF
Sci Rep; 2021 Jan; 11(1):981. PubMed ID: 33441691
[TBL] [Abstract][Full Text] [Related]
15. Antireflux surgery normalizes cyclooxygenase-2 expression in squamous epithelium of the distal esophagus.
Vallböhmer D; DeMeester SR; Oh DS; Banki F; Kuramochi H; Shimizu D; Hagen JA; Danenberg KD; Danenberg PV; Chandrasoma PT; Peters JH; DeMeester TR
Am J Gastroenterol; 2006 Jul; 101(7):1458-66. PubMed ID: 16863546
[TBL] [Abstract][Full Text] [Related]
16. COX-2 mRNA expression is significantly increased in acid-exposed compared to nonexposed squamous epithelium in gastroesophageal reflux disease.
Lurje G; Vallbohmer D; Collet PH; Xi H; Baldus SE; Brabender J; Metzger R; Heitmann M; Neiss S; Drebber U; Holscher AH; Schneider PM
J Gastrointest Surg; 2007 Sep; 11(9):1105-11. PubMed ID: 17619937
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathways: pathogenesis and clinical implications of microbiome alteration in esophagitis and Barrett esophagus.
Yang L; Francois F; Pei Z
Clin Cancer Res; 2012 Apr; 18(8):2138-44. PubMed ID: 22344232
[TBL] [Abstract][Full Text] [Related]
18. Clinical, endoscopic, and functional studies in 408 patients with Barrett's esophagus, compared to 174 cases of intestinal metaplasia of the cardia.
Csendes A; Smok G; Quiroz J; Burdiles P; Rojas J; Castro C; Henríquez A
Am J Gastroenterol; 2002 Mar; 97(3):554-60. PubMed ID: 11922546
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of Helicobacter pylori infection in 190 control subjects and in 236 patients with gastroesophageal reflux, erosive esophagitis or Barrett's esophagus.
Csendes A; Smok G; Cerda G; Burdiles P; Mazza D; Csendes P
Dis Esophagus; 1997 Jan; 10(1):38-42. PubMed ID: 9079272
[TBL] [Abstract][Full Text] [Related]
20. What is the clinical significance of stromal angiogenesis in Barrett's esophagus?
Moriyama N; Amano Y; Mishima Y; Okita K; Takahashi Y; Yuki T; Ishimura N; Ishihara S; Kinoshita Y
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S210-5. PubMed ID: 19120900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
